Preparation and evaluation of transdermal patches of papaverine hydrochloride

Prabhu Prabhakara, Marina Koland, K. Vijaynarayana, N. M. Harish, G. Shankar, Mohd Gulzar Ahmed, Charyulu R. Narayana, D. Satyanarayana

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Transdermal patches of Papaverine hydrochloride were prepared by solvent casting method using ethyl cellulose: PVP, PVA: PVP and eudragit RL-100: eudragit RS-100 in different ratios. The physicochemical parameters like flexibility, thickness, smoothness, weight variation, moisture content, hardness and tensile strength were evaluated and found to be flexible, uniform thickness and weight, smooth, good drug content (92 to 96%) and little moisture absorption. The in-vitro diffusion studies were carried out using modified Keshery-Chein cell with cellophane as diffusion membrane and the formulation followed Higuchi diffusion mechanism. The formulation containing PVA:PVP as polymers showed faster release rate (hydrophilic polymers) compared to eudragit RL-100:eudragit RS-100 (hydrophobic polymers) or combination of hydrophilic and hydrophobic polymers (Ethyl cellulose and PVP). The stability studies indicated that all the patches maintained good physicochemical properties and drug content after storing the patches in different storage conditions. Compatibility studies indicated that there was no interaction between the drug and polymers. In vivo studies showed that papaverine hydrochloride helps in decreasing the effect of isoproterenol induced myocardial necrosis.

Original languageEnglish
Pages (from-to)259-266
Number of pages8
JournalInternational Journal of Research in Pharmaceutical Sciences
Volume1
Issue number3
Publication statusPublished - 2010

Fingerprint

Transdermal Patch
Papaverine
Polymers
Cellophane
Weights and Measures
Tensile Strength
Hardness
Drug Interactions
Isoproterenol
Pharmaceutical Preparations
Necrosis
Membranes
Eudragit RS
ethyl cellulose

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Prabhakara, P., Koland, M., Vijaynarayana, K., Harish, N. M., Shankar, G., Ahmed, M. G., ... Satyanarayana, D. (2010). Preparation and evaluation of transdermal patches of papaverine hydrochloride. International Journal of Research in Pharmaceutical Sciences, 1(3), 259-266.
Prabhakara, Prabhu ; Koland, Marina ; Vijaynarayana, K. ; Harish, N. M. ; Shankar, G. ; Ahmed, Mohd Gulzar ; Narayana, Charyulu R. ; Satyanarayana, D. / Preparation and evaluation of transdermal patches of papaverine hydrochloride. In: International Journal of Research in Pharmaceutical Sciences. 2010 ; Vol. 1, No. 3. pp. 259-266.
@article{8d32e5f49b0845ec857104015d04c38b,
title = "Preparation and evaluation of transdermal patches of papaverine hydrochloride",
abstract = "Transdermal patches of Papaverine hydrochloride were prepared by solvent casting method using ethyl cellulose: PVP, PVA: PVP and eudragit RL-100: eudragit RS-100 in different ratios. The physicochemical parameters like flexibility, thickness, smoothness, weight variation, moisture content, hardness and tensile strength were evaluated and found to be flexible, uniform thickness and weight, smooth, good drug content (92 to 96{\%}) and little moisture absorption. The in-vitro diffusion studies were carried out using modified Keshery-Chein cell with cellophane as diffusion membrane and the formulation followed Higuchi diffusion mechanism. The formulation containing PVA:PVP as polymers showed faster release rate (hydrophilic polymers) compared to eudragit RL-100:eudragit RS-100 (hydrophobic polymers) or combination of hydrophilic and hydrophobic polymers (Ethyl cellulose and PVP). The stability studies indicated that all the patches maintained good physicochemical properties and drug content after storing the patches in different storage conditions. Compatibility studies indicated that there was no interaction between the drug and polymers. In vivo studies showed that papaverine hydrochloride helps in decreasing the effect of isoproterenol induced myocardial necrosis.",
author = "Prabhu Prabhakara and Marina Koland and K. Vijaynarayana and Harish, {N. M.} and G. Shankar and Ahmed, {Mohd Gulzar} and Narayana, {Charyulu R.} and D. Satyanarayana",
year = "2010",
language = "English",
volume = "1",
pages = "259--266",
journal = "International Journal of Research in Pharmaceutical Sciences",
issn = "0975-7538",
publisher = "JK Welfare & Pharmascope Foundation",
number = "3",

}

Prabhakara, P, Koland, M, Vijaynarayana, K, Harish, NM, Shankar, G, Ahmed, MG, Narayana, CR & Satyanarayana, D 2010, 'Preparation and evaluation of transdermal patches of papaverine hydrochloride', International Journal of Research in Pharmaceutical Sciences, vol. 1, no. 3, pp. 259-266.

Preparation and evaluation of transdermal patches of papaverine hydrochloride. / Prabhakara, Prabhu; Koland, Marina; Vijaynarayana, K.; Harish, N. M.; Shankar, G.; Ahmed, Mohd Gulzar; Narayana, Charyulu R.; Satyanarayana, D.

In: International Journal of Research in Pharmaceutical Sciences, Vol. 1, No. 3, 2010, p. 259-266.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Preparation and evaluation of transdermal patches of papaverine hydrochloride

AU - Prabhakara, Prabhu

AU - Koland, Marina

AU - Vijaynarayana, K.

AU - Harish, N. M.

AU - Shankar, G.

AU - Ahmed, Mohd Gulzar

AU - Narayana, Charyulu R.

AU - Satyanarayana, D.

PY - 2010

Y1 - 2010

N2 - Transdermal patches of Papaverine hydrochloride were prepared by solvent casting method using ethyl cellulose: PVP, PVA: PVP and eudragit RL-100: eudragit RS-100 in different ratios. The physicochemical parameters like flexibility, thickness, smoothness, weight variation, moisture content, hardness and tensile strength were evaluated and found to be flexible, uniform thickness and weight, smooth, good drug content (92 to 96%) and little moisture absorption. The in-vitro diffusion studies were carried out using modified Keshery-Chein cell with cellophane as diffusion membrane and the formulation followed Higuchi diffusion mechanism. The formulation containing PVA:PVP as polymers showed faster release rate (hydrophilic polymers) compared to eudragit RL-100:eudragit RS-100 (hydrophobic polymers) or combination of hydrophilic and hydrophobic polymers (Ethyl cellulose and PVP). The stability studies indicated that all the patches maintained good physicochemical properties and drug content after storing the patches in different storage conditions. Compatibility studies indicated that there was no interaction between the drug and polymers. In vivo studies showed that papaverine hydrochloride helps in decreasing the effect of isoproterenol induced myocardial necrosis.

AB - Transdermal patches of Papaverine hydrochloride were prepared by solvent casting method using ethyl cellulose: PVP, PVA: PVP and eudragit RL-100: eudragit RS-100 in different ratios. The physicochemical parameters like flexibility, thickness, smoothness, weight variation, moisture content, hardness and tensile strength were evaluated and found to be flexible, uniform thickness and weight, smooth, good drug content (92 to 96%) and little moisture absorption. The in-vitro diffusion studies were carried out using modified Keshery-Chein cell with cellophane as diffusion membrane and the formulation followed Higuchi diffusion mechanism. The formulation containing PVA:PVP as polymers showed faster release rate (hydrophilic polymers) compared to eudragit RL-100:eudragit RS-100 (hydrophobic polymers) or combination of hydrophilic and hydrophobic polymers (Ethyl cellulose and PVP). The stability studies indicated that all the patches maintained good physicochemical properties and drug content after storing the patches in different storage conditions. Compatibility studies indicated that there was no interaction between the drug and polymers. In vivo studies showed that papaverine hydrochloride helps in decreasing the effect of isoproterenol induced myocardial necrosis.

UR - http://www.scopus.com/inward/record.url?scp=77955670717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955670717&partnerID=8YFLogxK

M3 - Article

VL - 1

SP - 259

EP - 266

JO - International Journal of Research in Pharmaceutical Sciences

JF - International Journal of Research in Pharmaceutical Sciences

SN - 0975-7538

IS - 3

ER -